Astrocytic Aβ1-42 uptake is determined by Aβ-aggregation state and the presence of amyloid-associated proteins

GLIA

Volumn 58, Issue 10, 2010, Pages 1235-1246

  Nielsen, Henrietta M ^a,b   Mulder, Sandra D ^a,b   Beliën, Jeroen A M ^a   Musters, René J P ^a   Eikelenboom, Piet ^a   Veerhuis, Robert ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid clearance; Apolipo protein; Clusterin; Glial cell

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID P COMPONENT; APOLIPOPROTEIN E; CLUSTERIN; COMPLEMENT COMPONENT C1Q; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGOMER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXPOSURE; FEMALE; FIBER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AMYLOID; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; ASTROCYTES; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; CHEMOKINE CCL2; CLUSTERIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION;

EID: 77954375412     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21004     Document Type: Article

References (56)

1. Abraham CR, McGraw WT, Slot F, Yamin R. 2000. Alpha 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo. Ann NY Acad Sci 920:245-248. (Pubitemid 32056576)
2. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
3. Avramopoulos D. 2009. Genetics of Alzheimer's disease: Recent advances. Genome Med 1:34.
4. Baker C, Nielsen HM, Minthon L, Wright HT, Chappell S, Okyere J, May S, Morgan K, Kalsheker N, Janciauskiene SM. 2007. Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression. Neurobiol Aging 28:51-61.
5. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Yolk B, Berger M. 1991. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 285:111-114.
6. Bruinsma IB, Wilhelmus MM, Kox M, Veerhuis R, de Waal RM, Verbeek MM. 2010. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death. Brain Res 1315:169-180.
7. Chafekar SM, Baas F, Scheper W. 2008. Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake. Biochim Biophys Acta 1782:523-531.
8. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ. 2002. Oligomeric and fibrillar species of amyloi-deta peptides differentially affect neuronal viability. J Biol Chem 277:32046-32053.
9. De Groot CJ, Langeveld CH, Jongenelen CA, Montagne L, Van Der Valk P, Dijkstra CD. 1997. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: Immunophenotypical and functional characterization. J Neurosci Res 49:342-354.
10. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. 1991. Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases. Acta Neuropathol 81:328-335.
11. DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM, Holtzman DM. 2004. ApoE and clusterin cooperatively suppress Abeta levels and deposition: Evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41:193-202.
12. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ. 2006. The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 113:1685-1695. (Pubitemid 44657664)
13. Eikelenboom P, Zhan SS, Kamphorst W, van der Valk P, Rozemuller JM. 1994. Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch 424:421-427. (Pubitemid 24185396)
14. Familian A, Eikelenboom P, Veerhuis R. 2007. Minocycline does not affect amyloid beta phagocytosis by human microglial cells. Neurosci Lett 416:87-91.
15. Fan J, Donkin J, Wellington C. 2009. Greasing the wheels of Abeta clearance in Alzheimer's disease: The role of lipids and apolipoprotein E. Biofactors 35:239-248.
16. Fraser PE, Nguyen JT, McLachlan DR, Abraham CR, Kirschner DA. 1993. Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem 61:298-305.
17. Griffin WS, Sheng JG, Roberts GW, Mrak RE. 1995. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 54:276-281.
18. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356.
19. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. 2009. Genome-wide association study identifies variants at CLU, PICALM associated with Alzheimer's disease. Nat Genet 41:1088-1093.
20. Hu J, Van Eldik LJ. 1999. Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation. Brain Res 842:46-54.
21. Hughes SR, Khorkova O, Goyal S, Knaeblein J, Heroux J, Riedel NG, Sahasrabudhe S. 1998. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci USA 95:3275-3280.
22. Ikeda S, Yanagisawa N, Allsop D, Glenner GG. 1990. Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy. Hum Pathol 21:1221-1226.
23. Janciauskiene S, Garcia de Frutos P, Carlemalm E, Dahlback B, Eriksson S. 1995. Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component. J Biol Chem 270:26041-26044.
24. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE. 2008. ApoE promotes the proteolytic degradation of Abeta. Neuron 58:681-693.
25. Kandimalla KK, Scott OG, Fulzele S, Davidson MW, Poduslo JF. 2009. Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein. PLoS One 4:e4627.
26. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM. 2004. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloidbeta peptides. Nat Med 10:719-726.
27. Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ. 2009. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650-657.
28. Korzeniewski C, Callewaert DM. 1983. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64:313-320.
29. Krijnen PA, Cillessen SA, Manoe R, Muller A, Visser CA, Meijer CJ, Musters RJ, Hack CE, Aarden LA, Niessen HW. 2005. Clusterin: A protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol 289:H2193-H2202.
30. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P. 2009. Genome-wide association study identifies variants at CLU, CR1 associated with Alzheimer's disease. Nat Genet 41:1094-1099.
31. Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, Depraetere S, van Kooyk Y, Geijtenbeek TB. 2004. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol 78:8322-8332.
32. Ma J, Yee A, Brewer HB Jr, Das S, Potter H. 1994. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372:92-94. (Pubitemid 2150750)
33. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE. 2009. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29:4252-4262.
34. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S. 2009. Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 57:978-988.
35. Nuutinen T, Huuskonen J, Suuronen T, Ojala J, Miettinen R, Salminen A. 2007. Amyloideta 1-42 induced endocytosis and clusterin/apoJ protein accumulation in cultured human astrocytes. Neurochem Int 50:540-547.
36. Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, Rozovsky I, Stine WB, Snyder SW, Holzman TF, Krafft GA, Finch CE. 1995. Clusterin (apoJ) alters the aggregation of amyloid betapeptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol 136:22-31.
37. Pihlaja R, Koistinaho J, Malm T, Sikkila H, Vainio S, Koistinaho M. 2008. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Glia 56:154-163.
38. Resende R, Ferreiro E, Pereira C, Resende de Oliveira C. 2008. Neurotoxic effect of oligomeric and fibrillar species of amyloi-deta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 155:725-737.
39. Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y, Wagner E, Parratt A, Xu J, Li Z, Zaleska MM, Jacobsen JS, Pangalos MN, Reinhart PH. 2008. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28:11445-11453.
40. Rozemuller JM, Abbink JJ, Kamp AM, Stam FC, Hack CE, Eikelenboom P. 1991. Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. Acta Neuropathol (Berl) 82:200-207.
41. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL. 1989. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 48:674-691.
42. Simunek T, Boer C, Bouwman RA, Vlasblom R, Versteilen AM, Sterba M, Gersl V, Hrdina R, Ponka P, de Lange JJ, Paulus WJ, Musters RJ. 2005. SIH-a novel lipophilic iron chelator-protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. J Mol Cell Cardiol 39:345-354.
43. Sokolova A, Hill MD, Rahimi F, Warden LA, Halliday GM, Shepherd CE. 2009. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol 19:392-398.
44. Tennent GA, Lovat LB, Pepys MB. 1995. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci USA 92:4299-4303.
45. Thal DR, Schultz C, Dehghani F, Yamaguchi H, Braak H, Braak E. 2000. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. Acta Neuropathol (Berl) 100:608-617.
46. van der Sar AM, Musters RJ, van Eeden FJ, Appelmelk BJ, Vandenbroucke-Grauls CM, Bitter W. 2003. Zebrafish embryos as a model host for the real time analysis of Salmonella typhimurium infections. Cell Microbiol 5:601-611.
47. Veerhuis R, Boshuizen RS, Familian A. 2005. Amyloid associated proteins in Alzheimer's and prion disease. Curr Drug Targets CNS Neurol Disord 4:235-248.
48. Veerhuis R, Van Breemen MJ, Hoozemans JM, Morbin M, Ouladhadj J, Tagliavini F, Eikelenboom P. 2003. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol 105:135-144.
49. Verwey NA, Schuitemaker A, van der Flier WM, Mulder SD, Mulder C, Hack CE, Scheltens P, Blankenstein MA, Veerhuis R. 2008. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 26:522-527.
50. White JA, Manelli AM, Holmberg KH, Van Eldik LJ, Ladu MJ. 2005. Differential effects of oligomeric and fibrillar amyloideta 1-42 on astrocyte-mediated inflammation. Neurobiol Dis 18:459-465.
51. Wilhelmus MM, Otte-Holler I, van Triel JJ, Veerhuis R, Maat-Schieman ML, Bu G, de Waal RM, Verbeek MM. 2007. Lipoprotein receptorrelated protein-1 mediates amyloideta-mediated cell death of cerebrovascular cells. Am J Pathol 171:1989-1999.
52. Wisniewski HM, Wegiel J. 1991. Spatial relationships between astrocytes and classical plaque components. Neurobiol Aging 12:593-600.
53. Wouterlood FG, Boekel AJ, Meijer GA, Belien JA. 2007. Computerassisted estimation in the CNS of 3D multimarker 'overlap' or 'touch' at the level of individual nerve endings: A confocal laser scanning microscope application. J Neurosci Res 85:1215-1228.
54. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. 2003. Adult mouse astrocytes degrade amyloideta in vitro and in situ. Nat Med 9:453-457.
55. Yamaguchi H, Sugihara S, Ogawa A, Saido TC, Ihara Y. 1998. Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol (Berl) 95:217-222. (Pubitemid 28120665)
56. Zhan SS, Veerhuis R, Kamphorst W, Eikelenboom P. 1995. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration 4:291-297.